Literature DB >> 31343657

Appraising the Tail of the Survival Curve in the Era of PD-1/PD-L1 Checkpoint Blockade.

Stefan Zimmermann1, Solange Peters1.   

Abstract

Entities:  

Year:  2019        PMID： 31343657     DOI： 10.1001/jamaoncol.2019.2186

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach.

Authors:  Julia Grigorieva; Senait Asmellash; Lelia Net; Maxim Tsypin; Heinrich Roder; Joanna Roder
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

2.  Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic Review.

Authors:  Thomas Filleron; Marine Bachelier; Julien Mazieres; Maurice Pérol; Nicolas Meyer; Elodie Martin; Fanny Mathevet; Jean-Yves Dauxois; Raphael Porcher; Jean-Pierre Delord
Journal:  JAMA Netw Open       Date:  2021-12-01

3.  Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).

Authors:  Michael B Atkins; Hamzah Abu-Sbeih; Paolo A Ascierto; Michael R Bishop; Daniel S Chen; Madhav Dhodapkar; Leisha A Emens; Marc S Ernstoff; Robert L Ferris; Tim F Greten; James L Gulley; Roy S Herbst; Rachel W Humphrey; James Larkin; Kim A Margolin; Luca Mazzarella; Suresh S Ramalingam; Meredith M Regan; Brian I Rini; Mario Sznol
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

4.  Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.

Authors:  Robin Kate Kelley; Bruno Sangro; William Harris; Masafumi Ikeda; Takuji Okusaka; Yoon-Koo Kang; Shukui Qin; David W-M Tai; Ho Yeong Lim; Thomas Yau; Wei-Peng Yong; Ann-Lii Cheng; Antonio Gasbarrini; Silvia Damian; Jordi Bruix; Mitesh Borad; Johanna Bendell; Tae-You Kim; Nathan Standifer; Philip He; Mallory Makowsky; Alejandra Negro; Masatoshi Kudo; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.